Morgan Stanley
HQL

Morgan Stanley’s abrdn Life Sciences Investors HQL Stock Holding History

Morgan Stanley’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.6M Buy
1,571,014
+406,188
+35% +$6.79M ﹤0.01% 2716
2025
Q4 		$19.5M Buy
1,164,826
+294,168
+34% +$4.94M ﹤0.01% 2955
2025
Q3 		$13.5M Buy
870,658
+104,449
+14% +$1.43M ﹤0.01% 3280
2025
Q2 		$9.82M Buy
766,209
+247,674
+48% +$3.05M ﹤0.01% 3457
2025
Q1 		$6.58M Buy
518,535
+152,849
+42% +$2.07M ﹤0.01% 3691
2024
Q4 		$4.8M Sell
365,686
-124,001
-25% -$1.79M ﹤0.01% 4038
2024
Q3 		$7.38M Sell
489,687
-453
-0.1% -$6.86K ﹤0.01% 3658
2024
Q2 		$6.95M Buy
490,140
+5,962
+1% +$80.6K ﹤0.01% 3622
2024
Q1 		$6.6M Sell
484,178
-376,354
-44% -$5.21M ﹤0.01% 3687
2023
Q4 		$11.6M Buy
860,532
+198,894
+30% +$2.45M ﹤0.01% 3804
2023
Q3 		$8.25M Buy
661,638
+82,703
+14% +$1.09M ﹤0.01% 3298
2023
Q2 		$7.84M Buy
578,935
+48,400
+9% +$668K ﹤0.01% 3405
2023
Q1 		$7.39M Buy
530,535
+86,482
+19% +$1.24M ﹤0.01% 3423
2022
Q4 		$6.31M Buy
444,053
+36,706
+9% +$532K ﹤0.01% 3535
2022
Q3 		$5.56M Buy
407,347
+8,914
+2% +$133K ﹤0.01% 3592
2022
Q2 		$5.67M Sell
398,433
-34,516
-8% -$521K ﹤0.01% 3651
2022
Q1 		$7.16M Buy
432,949
+53,411
+14% +$919K ﹤0.01% 3290
2021
Q4 		$7.3M Sell
379,538
-37,403
-9% -$753K ﹤0.01% 3314
2021
Q3 		$8.67M Sell
416,941
-6,407
-2% -$137K ﹤0.01% 3062
2021
Q2 		$9.08M Buy
423,348
+27,762
+7% +$560K ﹤0.01% 3102
2021
Q1 		$7.8M Sell
395,586
-27,783
-7% -$573K ﹤0.01% 2912
2020
Q4 		$8.36M Sell
423,369
-21,732
-5% -$402K ﹤0.01% 2707
2020
Q3 		$7.83M Buy
445,101
+27,869
+7% +$499K ﹤0.01% 2255
2020
Q2 		$7.49M Buy
417,232
+21,558
+5% +$370K ﹤0.01% 2246
2020
Q1 		$5.93M Buy
395,674
+14,371
+4% +$235K ﹤0.01% 2289
2019
Q4 		$6.65M Buy
381,303
+45,926
+14% +$754K ﹤0.01% 2873
2019
Q3 		$5.06M Sell
335,377
-25,830
-7% -$414K ﹤0.01% 2862
2019
Q2 		$6.09M Sell
361,207
-3,287
-0.9% -$54.1K ﹤0.01% 2715
2019
Q1 		$6.24M Sell
364,494
-38,247
-9% -$660K ﹤0.01% 2499
2018
Q4 		$6.08M Sell
402,741
-159,996
-28% -$2.82M ﹤0.01% 2671
2018
Q3 		$11.5M Sell
562,737
-59,170
-10% -$1.18M ﹤0.01% 2267
2018
Q2 		$11.7M Sell
621,907
-30,970
-5% -$583K ﹤0.01% 2197
2018
Q1 		$12.5M Buy
652,877
+27,454
+4% +$550K ﹤0.01% 2118
2017
Q4 		$12.3M Sell
625,423
-25,186
-4% -$504K ﹤0.01% 2191
2017
Q3 		$14M Buy
650,609
+47,452
+8% +$1.01M ﹤0.01% 1939
2017
Q2 		$12.6M Buy
603,157
+47,154
+8% +$953K ﹤0.01% 1948
2017
Q1 		$10.8M Sell
556,003
-5,976
-1% -$111K ﹤0.01% 2120
2016
Q4 		$9.55M Buy
561,979
+17,433
+3% +$306K ﹤0.01% 2306
2016
Q3 		$10.2M Sell
544,546
-15,439
-3% -$291K ﹤0.01% 1991
2016
Q2 		$9.63M Sell
559,985
-141,013
-20% -$2.6M ﹤0.01% 2012
2016
Q1 		$12.6M Buy
700,998
+29,050
+4% +$527K ﹤0.01% 1673
2015
Q4 		$15.9M Sell
671,948
-5,366
-0.8% -$133K 0.01% 1584
2015
Q3 		$15.2M Buy
677,314
+36,056
+6% +$1.01M 0.01% 1607
2015
Q2 		$18.1M Buy
641,258
+76,038
+13% +$2.11M 0.01% 1585
2015
Q1 		$15.6M Buy
565,220
+17,686
+3% +$482K 0.01% 1663
2014
Q4 		$13.6M Sell
547,534
-32,143
-6% -$771K 0.01% 1782
2014
Q3 		$12.8M Buy
579,677
+68,535
+13% +$1.49M ﹤0.01% 1812
2014
Q2 		$10.6M Buy
511,142
+38,581
+8% +$810K ﹤0.01% 1988
2014
Q1 		$10.3M Buy
472,561
+5,333
+1% +$119K ﹤0.01% 1945
2013
Q4 		$9.55M Buy
467,228
+35,785
+8% +$694K ﹤0.01% 1988
2013
Q3 		$8.31M Buy
431,443
+28,381
+7% +$544K ﹤0.01% 1929
2013
Q2 		$7.2M Buy
+403,062
New +$7.28M ﹤0.01% 1979

Other funds holding HQL

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return

Morgan Stanley's HQL Position: Q1 2026 in Review

Morgan Stanley increased its abrdn Life Sciences Investors (HQL) stake by 35% in Q1 2026, buying an estimated $6.79M and bringing the position to 1,571,014 shares worth $25.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2716.

Morgan Stanley first reported a position in HQL in Q2 2013 and has held it in 52 quarters since. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.

  • Morgan Stanley held 1,571,014 shares of abrdn Life Sciences Investors worth $25.6M as of Q1 2026.
  • Morgan Stanley bought 406,188 abrdn Life Sciences Investors shares in Q1 2026, an estimated $6.79M.
  • abrdn Life Sciences Investors made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #2716 holding.
  • Morgan Stanley first reported a position in abrdn Life Sciences Investors in Q2 2013 and has held it in 52 quarters since.
  • 86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.